The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
Status:
Completed
Trial end date:
2020-02-27
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the gut microbiota and clinical outcomes of
oral FMT during antibiotic treatment, immediately following antibiotic treatment, and
placebo. The second objective is to assess the safety and feasibility of daily oral Fecal
Microbiome Transplant (FMT) as a treatment option.